Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Politics
Business
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Merck
News Digest
The FDA has approved Merck's drug to treat a rare, deadly lung disease
The Food and Drug Administration has approved pharma giant Merck’s drug to treat a rare and sometimes deadly lung condition, Merck and the agency said Tuesday.
FDA Approves Merck’s New Drug For A Rare Lung Disease
The pharmaceutical giant’s new treatment, sotatercept, showed significant benefits for the thousands of patients suffering from pulmonary arterial hypertension in clinical trials.
Merck drug for rare cardiovascular condition approved in U.S.
Pulmonary arterial hypertension, a rare but deadly condition that primarily affects women, is poised to get a treatment from Merck that has a novel mechanism.
Supreme Court, Abortion Pill Access
News Digest
Supreme Court appears inclined to preserve broad access to abortion drug
The Supreme Court is preparing to dissolve matters that restrict access to the abortion drug mifepristone, which was encouraged by the Food and Drug Administration.
As Supreme Court weighs abortion drug, a look at pill usage since Roe v. Wade
The Supreme Court is hearing arguments this week for a case determining access to the abortion drug mifepristone. The restriction of mifepristone could make it more difficult for millions of women to end a pregnancy in states where abortion is legal.
Supreme Court Seems Inclined to Reject Bid to Curtail Abortion Pill Access
A majority of the Supreme Court appeared deeply skeptical on Tuesday of efforts to severely curtail access to a widely used abortion pill, questioning whether a group of anti-abortion doctors and organizations had a right to challenge the Food and Drug Administration’s approval of the medication.
6m
US FDA extends review of Applied Therapeutics' genetic disease drug
The FDA delayed its decision on the drug, govorestat, saying it requires additional time to review supplemental analyses ...
1d
on MSN
The FDA has approved Merck's drug to treat a rare, deadly lung disease
The Food and Drug Administration has approved pharma giant Merck’s drug to treat a rare and sometimes deadly lung condition, ...
8h
on MSN
Amazon, Rite Aid Can’t Get Enough Supply of Weight-Loss Drug Zepbound
Rite Aid Corp. and Amazon Pharmacy confirmed that Eli Lilly & Co.’s new weight-loss drug Zepbound is in short supply, as ...
2d
FDA Approves Merck’s New Drug For A Rare Lung Disease
The pharmaceutical giant’s new treatment, sotatercept, showed significant benefits for the thousands of patients suffering ...
2d
on MSN
Supreme Court appears inclined to preserve broad access to abortion drug
The Supreme Court is preparing to dissolve matters that restrict access to the abortion drug mifepristone, which was ...
phillyvoice.com
1d
New drug protects people with weakened immune systems from COVID-19
The FDA has authorized Pemgarda, an infusion therapy that benefits people undergoing cancer treatment and organ transplant ...
Everyday Health
2h
How Safe Are Food Preservatives?
Discover the impact of whole foods vs. ultra-processed foods on health, the role of food additives, and the safety of ...
DogTime on MSN
15h
Ollie: Has the Dog Food Brand Issued a Recall?
In the pet food sector, recalls play a crucial role in protecting the health and happiness of our beloved canine friends.
STAT
2d
Merck drug for rare cardiovascular condition approved in U.S.
Pulmonary arterial hypertension, a rare but deadly condition that primarily affects women, is poised to get a treatment from ...
The Business Journals
1d
Two years after initial rejection, Akebia’s anemia drug finally gets FDA approval
Two years after Akebia Therapeutics received a rejection letter from the U.S. Food and Drug Administration over a drug it ...
JD Supra
4h
Biden Administration Proposes Biosimilar Substitution Without Interchangeability
The Biden Administration recently released a 2025 Budget Proposal which includes permitting biosimilar substitution without the Food and ...
SCOTUSblog
2d
Food and Drug Administration v. Alliance for Hippocratic Medicine
Issues: (1) Whether respondents have Article III standing to challenge the Food and Drug Administration’s 2016 and 2021 actions with respect to mifepristone’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results